These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 19363237)
1. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases. Horvath B; Szapary L; Debreceni L; Feher G; Kenyeres P; Fulop A; Battyani I; Toth K Clin Hemorheol Microcirc; 2009; 42(1):19-28. PubMed ID: 19363237 [TBL] [Abstract][Full Text] [Related]
2. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. Potter K; Hankey GJ; Green DJ; Eikelboom J; Jamrozik K; Arnolda LF BMC Cardiovasc Disord; 2008 Sep; 8():24. PubMed ID: 18803866 [TBL] [Abstract][Full Text] [Related]
3. High-dose atorvastatin treatment in patients with peripheral arterial disease: effects on platelet aggregation, blood rheology and plasma homocysteine. van der Loo B; Spring S; Koppensteiner R Clin Hemorheol Microcirc; 2011; 47(4):241-51. PubMed ID: 21654053 [TBL] [Abstract][Full Text] [Related]
4. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults. Carlsson CM; Pharo LM; Aeschlimann SE; Mitchell C; Underbakke G; Stein JH Am Heart J; 2004 Sep; 148(3):E11. PubMed ID: 15389247 [TBL] [Abstract][Full Text] [Related]
5. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592 [TBL] [Abstract][Full Text] [Related]
6. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial. Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356 [TBL] [Abstract][Full Text] [Related]
7. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients. Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344 [TBL] [Abstract][Full Text] [Related]
8. [Homocysteine as a coronary risk factor]. Derbeneva SA; Pogozheva AV Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617 [TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326 [TBL] [Abstract][Full Text] [Related]
10. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis? Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546 [TBL] [Abstract][Full Text] [Related]
11. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study. Mann JF; Sheridan P; McQueen MJ; Held C; Arnold JM; Fodor G; Yusuf S; Lonn EM; Nephrol Dial Transplant; 2008 Feb; 23(2):645-53. PubMed ID: 18003666 [TBL] [Abstract][Full Text] [Related]
12. [The role of homocysteine thiolactone in some of human diseases]. Sikora M; Twardowski T; Jakubowski H Postepy Biochem; 2006; 52(4):417-23. PubMed ID: 17536511 [TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy. Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058 [TBL] [Abstract][Full Text] [Related]
14. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Budoff MJ; Ahmadi N; Gul KM; Liu ST; Flores FR; Tiano J; Takasu J; Miller E; Tsimikas S Prev Med; 2009; 49(2-3):101-7. PubMed ID: 19573556 [TBL] [Abstract][Full Text] [Related]
15. Homocysteine or renal impairment: which is the real cardiovascular risk factor? Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552 [TBL] [Abstract][Full Text] [Related]
16. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease. Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients. Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473 [TBL] [Abstract][Full Text] [Related]
19. [The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure]. Kozłowska I Ann Acad Med Stetin; 2004; 50(1):87-95. PubMed ID: 16871747 [TBL] [Abstract][Full Text] [Related]
20. Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes. Weijun G; Juming L; Guoqing Y; Jingtao D; Qinghua G; Yiming M; Changyu P Adv Ther; 2008 Sep; 25(9):884-93. PubMed ID: 18781288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]